Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For YNGA.L
Valuation Weak
14%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -3.92 0.32 0.33
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 111.32 8.12 3.84
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 5.04 13.13 12.50
Cash 2002.51 0.29 0.01
Capex 0.06 -0.41 -0.41
Free Cash Flow 37.70 0.17 0.12
Revenue -2.60 3.27 3.36
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin -13.31 0.14 0.16
Operating Margin -13.31 0.14 0.16
ROA -71.52 < 0.005 0.02
ROE -65.69 < 0.005 0.02
ROIC 70.62 0.04 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of YNGA.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of YNGA.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of YNGA.L is permitted for members.